Ionis Pharmaceuticals (IONS)
(Delayed Data from NSDQ)
$41.59 USD
-0.25 (-0.60%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $41.60 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/7/24 |
---|---|
Current Quarter | -1.01 |
EPS Last Quarter | -0.06 |
Last EPS Surprise | 92.31% |
ABR | 1.84 |
Earnings ESP
|
8.05% |
---|---|
Current Year | -3.69 |
Next Year | -3.23 |
EPS (TTM) | -2.56 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 140.39M | 143.86M | 616.90M | 714.43M |
# of Estimates | 7 | 7 | 6 | 7 |
High Estimate | 172.80M | 161.01M | 653.42M | 835.49M |
Low Estimate | 112.89M | 125.05M | 587.61M | 571.20M |
Year ago Sales | 131.00M | 188.00M | 788.00M | 616.90M |
Year over Year Growth Est. | 7.17% | -23.48% | -21.71% | 15.81% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.01 | -1.06 | -3.69 | -3.23 |
# of Estimates | 7 | 5 | 8 | 8 |
Most Recent Consensus | -1.02 | -0.82 | -2.46 | -2.00 |
High Estimate | -0.84 | -0.82 | -2.46 | -2.00 |
Low Estimate | -1.22 | -1.24 | -4.35 | -5.12 |
Year ago EPS | -0.87 | -0.60 | -2.56 | -3.69 |
Year over Year Growth Est. | -16.09% | -76.67% | -44.14% | 12.33% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 3 |
Up Last 60 Days | 1 | 1 | 1 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 2 | 2 |
Down Last 60 Days | 1 | 0 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.01 | -1.06 | -3.69 | -3.23 |
7 Days Ago | -1.01 | -1.06 | -3.69 | -3.24 |
30 Days Ago | -1.08 | -1.07 | -3.79 | -3.39 |
60 Days Ago | -1.08 | -1.07 | -3.79 | -3.39 |
90 Days Ago | -0.94 | -1.01 | -3.57 | -3.32 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.93 | -0.95 | -3.66 | -2.84 |
Zacks Consensus Estimate | -1.01 | -1.06 | -3.69 | -3.23 |
Earnings ESP | 8.05% | 11.18% | 0.75% | 12.08% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.06 | -1.03 | -0.60 | -0.87 | NA |
Estimate | -0.78 | -1.01 | -0.94 | -1.00 | NA |
Difference | 0.72 | -0.02 | 0.34 | 0.13 | 0.29 |
Surprise | 92.31% | -1.98% | 36.17% | 13.00% | 34.88% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more